Riskpilot← Back to searchSign inGet full accessPalæklinikken Holding ApS
APSActiveCVR 38043331Herlev Bygade 14, 1.Other financial service activities, except insurance and pension funding n.e.c. · NACE 6499Est. 2016— employees
Revenue 2024
DKK -25K
+16% vs 2023
EBITDA margin
100.0%
-16% vs 2023
Equity ratio
99.6%
Financial strength
Net profit 2024
DKK 882K
-77% vs 2023
| Revenue | DKK -25K | +16% |
| EBITDA | DKK -25K | -16% |
| Net profit | DKK 882K | -77% |
| Total assets | DKK 10M | +0% |
| Equity | DKK 10M | +0% |
| Employees | — | — |
Legal name
Palæklinikken Holding ApS
CVR number
38043331
Legal form
Anpartsselskab
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
16. september 2016
Share capital
DKK 50.000
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den administrerende direktør
Company purpose
Selskabets formål er at være holdingselskab og dermed investere i og eje kapitalandele i andre selskaber samt al virksomhed, som efter bestyrelsens skøn er beslægtet hermed.
Address
Herlev Bygade 14, 1.
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | -21 | -18 | -15 | -21 | -25 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -21 | -18 | -15 | -21 | -25 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | -21 | -18 | -15 | -21 | -25 |
| Net financials | 132 | -1 | -1 | 3.796 | 897 |
| Profit before tax | 111 | -19 | -16 | 3.775 | 873 |
| Tax | -1 | -0 | -0 | -0 | -9 |
| Net profit | 112 | -19 | -16 | 3.775 | 882 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5.521 | 10.029 | 10.027 | 10.034 | 10.040 |
| Equity | 5.452 | 9.960 | 9.944 | 10.019 | 10.000 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 69 | 69 | 84 | 15 | 40 |
| Total debt | 69 | 69 | 84 | 15 | 40 |
EBITDA margin
-2462500.0%
This company
15.8%
Market median
-15585543% vs market
20202024
Equity ratio
99.6%
This company
38.2%
Market median
+161% vs market
20202024
Return on equity
8.8%
This company
18.4%
Market median
-52% vs market
20202024
Net profit margin
88177500.0%
This company
8.1%
Market median
+1088611011% vs market
20202024
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (4) | ||
MR Chief Executive Officer | Chief Executive Officer | 2023 – 2025 |
SK Chief Executive Officer | Chief Executive Officer | 2018 – 2021 |
FM Management | Management | 2016 – 2018 |
JM Chief Executive Officer | Chief Executive Officer | 2021 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2025 | |
| Board of Directors | 2017 | |
| Board of Directors | 2025 | |
| Board of Directors | 2025 | |
| Former (4) | ||
| Chairman | 2016 – 2018 | |
| Chairman | 2019 – 2021 | |
| Board of Directors | 2016 – 2018 | |
| Chairman | 2018 – 2019 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 | |
| Company | 10–14.99% | 10–14.99% | 2019 | |
| Company | 10–14.99% | 10–14.99% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
COLOSSEUMKLINIKKEN DANMARK ApS
Palæklinikken Holding ApS Board members of Palæklinikken Holding ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mathias Riis Damgaard | Chief Executive Officer | 0 companies |
| Søren Kock | Chief Executive Officer | 0 companies |
| Frans Maarten van Berckel | Management | 0 companies |
| Jens Mondrup | Chief Executive Officer | 0 companies |
| Jacob Adelbertus Cornelis Vermeule | Chairman | 0 companies |
| Rasmus Maahr | Chairman | 0 companies |
| Malin Birgitta Schmidt | Chairman | 0 companies |
| Carsten Blok | Board of Directors | 0 companies |
| Pernille Schlütter Beck | Board of Directors | 0 companies |
| Jerry Mathen George | Board of Directors | 0 companies |
| Dominique Nicole Dr. Friederich | Chairman | 0 companies |
| Christopher Sebastian Östberg | Board of Directors | 0 companies |